Elena Yureneva

Sr Director, Global Patient Safety & Risk Mgmnt at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Elena Yureneva's Colleagues at Alnylam Pharmaceuticals
Krista Satterly

Senior Manager, Internal Communications

Contact Krista Satterly

Jacob Chused

Director Financial Planning & Analysis

Contact Jacob Chused

Christopher Bach

Manager, Compliance and Documentation

Contact Christopher Bach

Kalan Fasoldt

Associate Director, Quality, Standards and Compliance

Contact Kalan Fasoldt

Brian Whalley

Associate Director Field Operations

Contact Brian Whalley

Steve Dickinson

Associate Director, Quality IT Systems and Validation

Contact Steve Dickinson

Benjamin Salley

Sr. Specialist, Quality Assurance, Clinical

Contact Benjamin Salley

View All Elena Yureneva's Colleagues
Elena Yureneva's Contact Details
HQ
(617) 551-8200
Location
Greater Boston Area
Company
Alnylam Pharmaceuticals
Elena Yureneva's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Elena Yureneva
Elena Yureneva currently works for Alnylam Pharmaceuticals.
Elena Yureneva's role at Alnylam Pharmaceuticals is Sr Director, Global Patient Safety & Risk Mgmnt.
Elena Yureneva's email address is ***@alnylam.com. To view Elena Yureneva's full email address, please signup to ConnectPlex.
Elena Yureneva works in the SaaS industry.
Elena Yureneva's colleagues at Alnylam Pharmaceuticals are Krista Satterly, Jacob Chused, Christopher Bach, Kalan Fasoldt, Brian Whalley, Steve Dickinson, Benjamin Salley and others.
Elena Yureneva's phone number is (617) 551-8200
See more information about Elena Yureneva